Engagement Study for Participants With Factor V Leiden and Prothrombin G20210A Mutations
NCT07584265
Factor V Leiden, Prothrombin G20210A
London, United Kingdom
View Trial DetailsNCT Number: NCT01835483
To establish the overall agreement of the MassPLEX Factor II and Factor V Leiden Genotyping Test with bi-directional DNA sequencing for Factor II and Factor V Leiden.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Sequenom Center for Molecular Medicine, Grand Rapids, Michigan, United States
De-identified banked genomic DNA samples derived from whole blood from subjects with suspected thrombophilia will be collected from one or more clinical sites. Three clinical laboratory sites will analyze the samples with the FII/FVL Test. Bi-directional DNA sequencing will be performed on all samples at an independent core reference laboratory.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Samples are collected at time of suspected thrombotic event.
Overall percent agreement of the FII/FVL Test results to the bi-directional DNA sequencing results.
Sequenom, Inc.
Industry
A Multicenter Clinical Study to Determine the Performance Characteristics of the MassPLEX Factor II and Factor V Leiden Genotyping Test in Patients With Suspected Thrombophilia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07584265
Factor V Leiden, Prothrombin G20210A
London, United Kingdom
View Trial DetailsNCT07430397
Factor V Leiden, Prothrombin G20210A
London, United Kingdom
View Trial DetailsNCT06993740
Anesthesia, Cardiovascular Diseases
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT03161678
Cardiovascular Diseases, Embolism and Thrombosis
Lancaster, Pennsylvania, United States
View Trial Details